The Impact of Tumor Necrosis Factor Inhibitor Use on Cardiovascular Events in Ankylosing Spondylitis07/01/2020 - 06/30/2022 (PI)
SpondyloArthritis Research and Treatment Network
The impact of ankylosing spondylitis treatment on cardiovascular risk and events06/10/2020 - 06/10/2022 (PI)
Pfizer, Inc.